MALAT1 and gastric cancer: From the results of rescue assays, we clearly found that SQSTM1 knockdown could reverse NF-κB activation and IL-6 upregulation caused by MALAT1, and restored SQSTM1 could reverse the NF-κB/IL-6 inhibition induced by silencing MALAT1 in GC cells.